UBS Group
BNTX icon

UBS Group’s BioNTech BNTX Stock Holding History

UBS Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$621K Sell
6,990
-105,610
-94% -$10.9M ﹤0.01% 5916
2025
Q4 		$10.7M Hold
112,600
– – ﹤0.01% 3215
2025
Q3 		$11.1M Sell
112,600
-30,000
-21% -$3.21M ﹤0.01% 3183
2025
Q2 		$15.2M Buy
142,600
+14,300
+11% +$1.44M ﹤0.01% 2667
2025
Q1 		$11.7M Sell
128,300
-43,300
-25% -$4.85M ﹤0.01% 2866
2024
Q4 		$19.6M Buy
171,600
+4,300
+3% +$491K ﹤0.01% 2341
2024
Q3 		$19.9M Buy
167,300
+96,400
+136% +$8.86M ﹤0.01% 1834
2024
Q2 		$5.7M Buy
70,900
+32,600
+85% +$2.98M ﹤0.01% 2744
2024
Q1 		$3.53M Sell
38,300
-11,800
-24% -$1.13M ﹤0.01% 3348
2023
Q4 		$5.29M Buy
50,100
+13,800
+38% +$1.39M ﹤0.01% 2733
2023
Q3 		$3.94M Buy
+36,300
New +$4.01M ﹤0.01% 2805
2023
Q2 		– Sell
-35,000
Closed -$4.36M – 8951
2023
Q1 		$4.36M Buy
35,000
+15,000
+75% +$2.06M ﹤0.01% 2653
2022
Q4 		$3M Sell
20,000
-10,000
-33% -$1.54M ﹤0.01% 2975
2022
Q3 		$4.05M Buy
+30,000
New +$4.59M ﹤0.01% 2550
2022
Q2 		– Sell
-53,900
Closed -$9.19M – 10333
2022
Q1 		$9.19M Sell
53,900
-208,000
-79% -$35M ﹤0.01% 2004
2021
Q4 		$67.5M Sell
261,900
-25,400
-9% -$6.96M 0.02% 774
2021
Q3 		$78.4M Buy
287,300
+3,300
+1% +$1.05M 0.02% 632
2021
Q2 		$63.6M Buy
284,000
+134,000
+89% +$25.3M 0.02% 719
2021
Q1 		$16.4M Buy
+150,000
New +$15.9M 0.01% 1574

Other funds holding BNTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group's BNTX Position: Q1 2026 in Review

UBS Group reduced its BioNTech (BNTX) stake by 0.43% in Q1 2026, selling an estimated $106K and leaving 240,538 shares worth $21.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2519.

UBS Group first reported a position in BNTX in Q4 2019 and has held it in 26 quarters since. The position peaked at $95.4M in Q3 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • UBS Group held 240,538 shares of BioNTech worth $21.4M as of Q1 2026.
  • UBS Group sold 1,035 BioNTech shares in Q1 2026, an estimated $106K.
  • BioNTech made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2519 holding.
  • UBS Group first reported a position in BioNTech in Q4 2019 and has held it in 26 quarters since.
  • UBS Group's BioNTech position peaked at $95.4M in Q3 2021.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.